Asset Details
Do you wish to reserve the book?
Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?
Do you wish to request the book?
Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?
2017
Overview
Introduction
In 1979, the Copenhagen group around Dr. Skakkebaek introduced contralateral biopsy in patients with testicular germ cell tumour (GCT) as a means of early diagnosing a contralateral testicular tumour (Berthelsen et al. in Br Med J 2(6186):363–364,
1
). Although the rationale of contralateral biopsies is based on much of scientific evidence, no issue regarding the management of GCTs has been more controversial than the issue of contralateral biopsies (Heidenreich in BJU Int 104(9 Pt B):1346–1350,
2
; Grigor and Rorth in Eur Urol 23(1):129–135,
3
). A poll conducted during the GCT Consensus Meeting in Berlin 2011 revealed that 43 % of 60 leading experts would not recommend a contralateral biopsy and only 13.7 % would do the biopsy in all cases with GCT (Beyer et al. in Ann Oncol 24(4):878–888,
4
). Likewise, the European Association of Urology and the European Society of Medical Oncology offer only weak recommendations with respect to contralateral biopsies in their guidelines of testicular cancer (Albers et al. in Eur Urol 68(6):1054–1068,
5
; Oldenburg et al. in Ann Oncol 24(Suppl 6):vi125–vi132,
6
).
Conclusion
This review summarizes contemporary knowledge regarding contralateral biopsies to provide professionals caring for GCT patients with sufficient information to decide for or against the procedure in clinical practice.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Cancer
/ Humans
/ Male
/ Medicine
/ Neoplasms, Germ Cell and Embryonal - diagnosis
/ Neoplasms, Germ Cell and Embryonal - pathology
/ Neoplasms, Multiple Primary - diagnosis
/ Neoplasms, Multiple Primary - pathology
/ Oncology
/ Precancerous Conditions - diagnosis
/ Precancerous Conditions - pathology
/ Testes
/ Testicular Neoplasms - diagnosis
/ Testicular Neoplasms - pathology
/ Tumors
/ Urology
